#

Search

Blog


<< Go Back
GSK Pharma

Revenue up 0.36% at Rs 805.26 crore vs Rs 802.3 crore (Bloomberg estimate: Rs 970 crore). Ebitda down 4.66% at Rs 218.06 crore vs Rs 228.7 crore. (Bloomberg estimate: Rs 126.2 crore). Margin narrows 142 bps to 27.07% vs 28.5% (Bloomberg estimate: 13%). Net profit down 72.21% at Rs 45.72 crore vs Rs 164.56 crore (Bloomberg estimate: Rs 78.6 crore). View: Result is below expectation